The Global Catheter Stabilization Devices Market was valued at USD 1.6 billion in 2024 and is estimated to grow at a CAGR of 7% to reach USD 3.2 billion by 2034. Catheter stabilization devices are essential tools in clinical care, designed to securely anchor various types of catheters to the body, reducing movement, preventing dislodgement, and lowering the risk of migration. This stability not only safeguards the patient but also ensures accurate and uninterrupted delivery of medical treatments. The increasing global prevalence of chronic illnesses such as cancer, kidney failure, diabetes, and cardiovascular conditions is driving the need for long-term catheter use in clinical settings.
In addition, as infection control becomes a growing priority in hospitals, there is an increasing focus on preventing catheter-related infections through improved securement methods. An aging population that frequently requires catheter-based procedures and home care support further contributes to this market’s expansion. Fragile skin and susceptibility to infections in older adults heighten the need for secure and comfortable catheter fixation. The demand for high-quality, easy-to-apply stabilization devices is therefore rising rapidly, especially across facilities providing long-term and in-home healthcare services.
In 2024, the devices segment held a 32.7% share. These catheters are widely applied in intensive care, oncology, and emergency care for critical treatments such as drug administration and nutritional support. With the rise in demand for advanced therapies in these clinical areas, securement devices have become essential in minimizing complications like bloodstream infections, endocarditis, and septic conditions that stem from catheter movement or contamination. To reduce these risks, healthcare institutions and governing bodies have enforced stricter infection control protocols, many of which mandate the use of catheter securement tools. These regulatory shifts are boosting the adoption of securement devices across multiple care settings.
The general surgery segment generated USD 553.5 million in 2024. Catheters are used extensively in surgical procedures for delivering anesthesia, monitoring fluids, and tracking vital signs. Stabilization devices are indispensable in ensuring catheter placement remains intact during surgeries and post-operative care, especially during transitions from operating theaters to recovery areas. Hospitals are under pressure to lower rates of central line-associated bloodstream infections and surgical site infections, which often occur during surgical interventions. This is intensifying the demand for stabilization solutions that align with hospital safety initiatives and improve procedural outcomes.
U.S. Catheter Stabilization Devices Market was valued at USD 667.5 million in 2024 and is expected to reach USD 1.3 billion by 2034. Rising chronic disease cases across the country are driving the need for catheter-based treatments, and in turn, increasing the adoption of stabilization devices. U.S. hospitals follow stringent safety regulations set by various healthcare bodies, which require institutions to use standardized infection control practices. Failure to comply with these safety benchmarks could lead to reduced reimbursement and financial penalties, prompting providers to invest in securement devices. These trends are firmly positioning the U.S. as a key growth region in the global catheter stabilization space.
Companies such as BD, 3M, Cardinal Health, ConvaTec, and B. Braun currently dominate the industry and collectively hold around 65% of the total market share. Leading players in the catheter stabilization devices market are leveraging multiple strategies to boost their presence and secure long-term growth. A primary focus lies in the development of advanced, patient-friendly products that reduce infection risk and enhance application ease.
Companies are strengthening their R&D efforts to deliver innovative designs that cater to specific medical needs and accommodate fragile patient populations, such as the elderly. Geographic expansion through partnerships, local manufacturing, and strategic distribution agreements helps widen access to their product lines. Regulatory compliance is also a major focus, as firms align with evolving clinical standards to increase institutional trust.
This product will be delivered within 2-4 business days.
In addition, as infection control becomes a growing priority in hospitals, there is an increasing focus on preventing catheter-related infections through improved securement methods. An aging population that frequently requires catheter-based procedures and home care support further contributes to this market’s expansion. Fragile skin and susceptibility to infections in older adults heighten the need for secure and comfortable catheter fixation. The demand for high-quality, easy-to-apply stabilization devices is therefore rising rapidly, especially across facilities providing long-term and in-home healthcare services.
In 2024, the devices segment held a 32.7% share. These catheters are widely applied in intensive care, oncology, and emergency care for critical treatments such as drug administration and nutritional support. With the rise in demand for advanced therapies in these clinical areas, securement devices have become essential in minimizing complications like bloodstream infections, endocarditis, and septic conditions that stem from catheter movement or contamination. To reduce these risks, healthcare institutions and governing bodies have enforced stricter infection control protocols, many of which mandate the use of catheter securement tools. These regulatory shifts are boosting the adoption of securement devices across multiple care settings.
The general surgery segment generated USD 553.5 million in 2024. Catheters are used extensively in surgical procedures for delivering anesthesia, monitoring fluids, and tracking vital signs. Stabilization devices are indispensable in ensuring catheter placement remains intact during surgeries and post-operative care, especially during transitions from operating theaters to recovery areas. Hospitals are under pressure to lower rates of central line-associated bloodstream infections and surgical site infections, which often occur during surgical interventions. This is intensifying the demand for stabilization solutions that align with hospital safety initiatives and improve procedural outcomes.
U.S. Catheter Stabilization Devices Market was valued at USD 667.5 million in 2024 and is expected to reach USD 1.3 billion by 2034. Rising chronic disease cases across the country are driving the need for catheter-based treatments, and in turn, increasing the adoption of stabilization devices. U.S. hospitals follow stringent safety regulations set by various healthcare bodies, which require institutions to use standardized infection control practices. Failure to comply with these safety benchmarks could lead to reduced reimbursement and financial penalties, prompting providers to invest in securement devices. These trends are firmly positioning the U.S. as a key growth region in the global catheter stabilization space.
Companies such as BD, 3M, Cardinal Health, ConvaTec, and B. Braun currently dominate the industry and collectively hold around 65% of the total market share. Leading players in the catheter stabilization devices market are leveraging multiple strategies to boost their presence and secure long-term growth. A primary focus lies in the development of advanced, patient-friendly products that reduce infection risk and enhance application ease.
Companies are strengthening their R&D efforts to deliver innovative designs that cater to specific medical needs and accommodate fragile patient populations, such as the elderly. Geographic expansion through partnerships, local manufacturing, and strategic distribution agreements helps widen access to their product lines. Regulatory compliance is also a major focus, as firms align with evolving clinical standards to increase institutional trust.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
- B. Braun
- Baxter International
- Becton, Dickinson and Company
- Cardinal Health
- Centurion Medical Products
- ConvaTec
- Dale Medical Products
- DeRoyal Industries
- Merit Medical Systems
- Pepper Medical
- Smiths Medical
- TIDI Products
- VYGON
- Zibo Qichuang Medical Products
- 3M
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | June 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 1.6 Billion |
| Forecasted Market Value ( USD | $ 3.2 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
